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doi:10.1016/j.pedneo.2011.02.007Background: Nitric oxide (NO) deficiency contributes to chronic kidney disease progression. NO
deficiency could occur for many reasons, one of which is decreased NO synthase (NOS) abun-
dance and/or activity.
Methods: In these experiments, we studied two groups of male Sprague Dawley rats given
sham or surgical excision of both poles of the left kidney (at 2 days of age) followed by
sham or surgical removal of the right kidney at 10 days. Rats were sacrificed at 9 weeks
of age and the kidneys examined for abundance of neuronal NOS (nNOS)-a and -b, endothe-
lial NOS, arginase II, argininosuccinate synthase and lysate, protein arginine methyltrans-
ferase 1, dimethylarginine dimethylamino-hydrolase 1 and 2, as well as renal pathology.
Results: The 5/6 nephrectomy (NX) group showed renal dysfunction, severe rapidly progres-
sing glomerulosclerosis, and hypertension. Renal cortical nNOSa abundance was significantly
reduced, whereas nNOSb abundance was increased in the 5/6 NX group versus sham. Renal
endothelial NOS was unchanged. Next, renal protein arginine methyltransferase 1 abun-
dance was higher, whereas dimethylarginine dimethylamino-hydrolase 2 expression was
lower in the 5/6 NX group versus sham. Renal arginase II, argininosuccinate synthase, and
argininosuccinate lysate abundances were significantly decreased in 5/6 NX rats than those
in sham.t of Pediatrics, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University,
usung, Kaohsiung 833, Taiwan.
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nNOS in neonatal 5/6 nephrectomized rat 67Conclusion: The neonatal kidney is very susceptible to 5/6 NX-induced injury, and, as in
adults, reciprocal changes in the nNOSa and nNOSb in renal cortex occur during progression
of chronic kidney disease and may contribute to the injury.
Copyright ª 2011, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Nitric oxide (NO) deficiency occurs in humans and animals
with chronic kidney disease (CKD) and may contribute to
injury progression.1 In rats, development of CKD is associ-
ated with progressive loss of the a isoform of neuronal NO
synthase (nNOS) from the kidney cortex.1,2 Furthermore, as
nNOSa declines, the abundance of the nNOSb isoform
increases in adult rats subjected to 5/6 renal ablation/
infarction.3 These changes in the renal cortical nNOS
proteins may be causally linked to the progression of
CKD.1,2
In addition to NOS isoform abundance, renal NOS activity
can be regulated by asymmetric dimethylarginine (ADMA),
which is mainly regulated by protein arginine methyl-
transferase 1 (PRMT1, ADMA-synthesizing enzyme) and
dimethylarginine dimethylamino-hydrolase (DDAH) 1 and 2
(ADMA-metabolizing enzymes). Because we had shown that
increased renal PRMT1 expression and decreased renal
DDAH activity contributed to the increase of ADMA in adult
5/6 nephrectomy (NX) rats,2 we also intended to study the
ADMA-related enzymes in this neonatal 5/6 NX model.
Another possible mechanism for NO deficiency in CKD is
substrate L-arginine deficiency.1 Because decreased endog-
enous L-arginine synthesis [by argininosuccinate synthase
(ASS) and lysate (ASL)] and increased L-arginine consumption
by means of other metabolic pathways (e.g., arginase II)
could cause L-arginine deficiency. We also detected renal
arginase II, ASS, and ASL expression in neonatal 5/6 NX rats.
Children are more susceptible to kidney injury and
development of subsequent renal dysfunction than adults.4
In the normal adult, uninephrectomy (UNX) has a very mild
phenotype that develops slowly, whereas in neonatal rats,
UNX leads to rapidly evolving CKD and hypertension.5,6
In the present study, we investigated whether severe
reduction of renal mass by 5/6 NX in neonatal rats is also
associated with accelerated injury progression and/or
reciprocal changes in density of the renal cortical nNOS
isoforms, nNOSa and b. We also examined the L-arginine
and ADMA-related enzymes in this neonatal 5/6 NX model.
2. Methods
Studies were conducted on 14 male Sprague Dawley rat
pups (10-day old) subjected to either sham surgery (NZ 7)
or 5/6 NX (NZ 7), as described previously.7 Blood pressure
was measured by tail cuff at 8 weeks of age, and rats were
sacrificed at 9 weeks of age when an aortic blood sample
was collected for measurement of plasma creatinine and
blood urea nitrogen. The left kidney remnant was perfused
blood-free with cold phosphate-buffered saline, removed,
and weighed and a section placed in 10% buffered formalinfor pathology. The remainder was separated into cortex,
flash frozen in liquid nitrogen, and stored at 80C for
analysis. All studies were approved by the Institutional
Animal Care & Use Committee of Virginia Commonwealth
University and conducted in accordance with the standards
described in the National Institutes of Health Guide to the
Care and Use of Laboratory Animals.
Western blot analysis was conducted on kidney cortex
(100e200 mg total protein) using a mouse monoclonal anti-
body (Santa Cruz, Santa Cruz, CA, USA) for nNOSa detection,
and for nNOSb, we used a C-terminal rabbit polyclonal
antibody (Affinity BioReagents, Golden, CO, USA).
Membranes were stripped and reprobed for endothelial NOS
(eNOS) using a mouse monoclonal antibody (Transduction
Laboratories, Lexington, KY, USA). For PRMT1, DDAH, argi-
nase II, ASS, and ASL, we used 12% gels with an otherwise
identical protocol to that used for the NOS. For PRMT1, we
used a rabbit anti-PRMT1 antibody (Upstate; Billerica, MA,
USA, 1:2000 dilution, overnight incubation) and a goat anti-
rabbit antibody. For DDAH, we used a goat anti-rat DDAH1
antibody (Santa Cruz, 1:500 dilution, overnight incubation)
and a goat anti-rat DDAH2 antibody (Santa Cruz, 1:100
dilution, overnight incubation), followed by a secondary
donkey anti-goat antibody (Santa Cruz, 1:2000 dilution, 1
hour incubation). For arginase II, we used a rabbit antibody
(Santa Cruz, 1:1000 dilution, overnight incubation), followed
by a goat anti-rabbit IgG-horseradish peroxidase secondary
antibody. For ASS and ASL, we used a rabbit ASS polyclonal
antibody and a rabbit ASL polyclonal antibody (gifts from Dr.
Gotoh), followed by a goat anti-rabbit IgG-horseradish
peroxidase secondary antibody. Bands of interest were
visualized using SuperSignal West Pico reagent (Pierce,
Rockford, IL, USA) and quantified by densitometry as inte-
grated optical density factored for Ponceau red staining to
correct for any variations in total protein loading and for an
internal standard (rat cerebellum for nNOS, endothelial cell
lysate for eNOS). The protein abundance was represented as
integrated optical density/Ponceau Red/Std. All details of
these measurements were reported previously.2,3
Pathology was performed on 5-mm sections of formalin-
fixed kidney, blocked in paraffin wax, and stained with
periodic acid-Schiff. The level of renal injury was assessed
on a blinded basis by determining the sclerotic damage to
glomeruli using the 0 to 4þ scale, and were graded as
follows: 0, no changes; 1þ injury involved <25% damage to
the glomerulus; 2þ injury, 25%e50%; 3þ injury, 50%e75%;
and 4þ injury, 75%e100% damage. Data were represented
as percentage of damaged glomeruli (nZ 100) showing any
level of injury (scale 1þ to 4þ) as published previously.2
Results are presented as means  standard error. Para-
metric data were analyzed by unpaired t test and histo-
logically by Mann-Whitney U test. A p < 0.05 was
considered statistically significant.
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At 9 weeks of age, the 5/6 NX rats had lower body weight
(270  13 vs. 382  9, p < 0.01) and much higher kidney
weights (7.4  0.4 g vs. 1.5  0.1 g, p < 0.001) and blood
pressure than shams (193 11 vs. 125 5 mmHg, p< 0.001).
Both plasma creatinine and blood urea nitrogen levels were
markedly increased in 5/6 NX rats (1.45  0.20 vs.
0.36 0.04 mg/dL, p< 0.005 and 170 22 vs. 16 5 mg/dL,
respectively) compared with shams. These data have been
published previously.7 The total number of damaged
glomeruli (all levels of injury) was 3  1% in shams and was
much greater in the 5/6 NX group (63 5%, p< 0.01). RobustFigure 1 (A) Histologic changes in 5/6 NX rat and sham control.
surgery (right panel) and control (left panel) by periodic acid-Schif
(black bars) and 5/6 nephrectomized rats (gray bars) according to s
4þ >75%). )p < 0.05 versus sham. NX Z nephrectomy.induction of glomerulosclerosis was present in 5/6 NX rats as
early as 8 weeks after surgery (Figure 1A). Tubulointerstitial
fibrosis developed in parallel with glomerulosclerosis. As
shown in Figure 1B, there were more damaged glomeruli at
the 3þ (15.5 3.0 vs. 0%) and 4þ levels (22.5 5.0 vs. 0%) of
severity in the 5/6 NX rats 8 weeks after surgery versus sham.
This contrasted to themilder injury seen in adult male rats 15
weeksafter5/6NXversus shams (403%vs.102%,p<0.01;
data published previously2) as adult 5/6 NX rats had onlyw5%
and w10% damaged glomeruli at the 3þ and 4þ levels of
severity, respectively.2
The renal nNOSa abundance was reduced almost to zero
in the 5/6 NX group (Figure 2A), whereas nNOSb abundanceRepresentative photographs from a 5/6 NX rat 8 weeks after
f stain. BarZ 500 mm. (B) Percent damaged glomeruli in shams
everity of glomerular injury (1þ <25%; 2þ 25e50%; 3þ 51e75%;
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Figure 2 Relative abundance of renal cortex (A) nNOSa, (B) nNOSb, and (C) eNOS. Representative whole membranes show the
nNOSa (w160 kDa), nNOSb (w140 kDa), and eNOS (w150 kDa). NZ 7 per group. )p < 0.05 versus sham. nNOSaZ neuronal nitric
oxide synthase-a; nNOSb Z neuronal nitric oxide synthase-b; eNOS Z endothelial nitric oxide synthase.
nNOS in neonatal 5/6 nephrectomized rat 69was increased (Figure 2B). In contrast, renal cortical eNOS
protein abundance was more variable and was not different
between the two groups (Figure 2C).
Renal PRMT1 abundance was higher in the 5/6 NX group
versus sham (Figure 3A). We found no difference in renal
DDAH1 abundance between the two groups (Figure 3B),
whereas DDAH2 expression was lower in 5/6 NX group
versus sham (Figure 3C). Renal arginase II, ASS, and ASLabundances were significantly decreased in the 5/6 NX
group versus sham (Figure 4).4. Discussion
Reduction in renal mass is a commonly used model of CKD in
the rat, with progression of injury depending on several
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Figure 3 Relative abundance of renal cortex (A) PRMT1, (B) DDAH1, and (C) DDAH2. Representative Western blots of whole
membranes show PRMT1 (w42 kDa), DDAH1 (w34 kDa), and DDAH2 bands (w30 kDa). N Z 7 per group. )p < 0.05 versus sham.
PRMT1Z protein arginine methyltransferase 1; DDAH1Z dimethylarginine dimethylamino-hydrolase 1; DDAH2Z dimethylarginine
dimethylamino-hydrolase 2.
70 Y.-L. Tain et alfactors including amount of renal mass removed, time after
renal mass reduction, and sex- and strain-dependent
vulnerability to CKD. Age is also important, and in the
present study, we showed that after 5/6 NX, neonatal rats
develop rapidly progressing hypertension and kidney
damage over a course of 8 weeks. In the young adult
Sprague Dawley male, there is little hypertension and more
moderate damage, even 15 weeks after 5/6 NX.2 Thefindings are similar with UNX, which has a mild phenotype
that develops slowly in adults, whereas in neonatal rats,
UNX leads to rapidly evolving CKD and hypertension.5,6
There was a remarkable hypertrophic response of the
remnant left kidney in the neonates with increases of
w400%, whereas 5/6 NX in young adults led to increases of
w60% in left kidney weight.2 This exaggerated hypertrophic
response may contribute to the severity of the injury.
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Figure 4 Relative abundance of renal cortex (A) arginase II, (B) argininosuccinate synthase (ASS), and (C) argininosuccinate
lysate (ASL). Representative Western blots of whole membranes show arginase II (w40 kDa), ASS (w50 kDa), and ASL bands
(w50 kDa). N Z 7 per group. )p < 0.05 versus sham. ASS Z argininosuccinate synthase; ASL Z argininosuccinate lysate.
nNOS in neonatal 5/6 nephrectomized rat 71Recently, we reported the existence of two isoforms of
nNOS (splice variants) in the normal rat kidney.3 The nNOSa
decreases as severity of kidney injury progresses, irre-
spective of the model.1 In situations where renal cortical
nNOS is preserved (because of sex- or strain-dependent
resistance to progression of CKD), the cortical nNOSaabundance is also preserved, suggesting a causal relation-
ship.1 The abundance of nNOSb increased in adult rats after
5/6 ablation infarction of renal mass,3 and we also reported
increased nNOSb abundance in a rapamycin-treated trans-
plant model.8 Because nNOSb abundance increases in
parallel with increasing glomerular damage, if this is
72 Y.-L. Tain et alintended as a compensatory effect, it is clearly inadequate
to prevent progression of the injury. In accordance with our
previous findings in adult rats, we found that nNOSa
decreased, but nNOSb increased in 5/6 NX rats when
surgery was performed in neonates. These changes were
very marked and paralleled the severity of the renal injury.
On the other hand, renal eNOS expression was unchanged in
5/6 NX rats (present study) and in adults.2
Next, we found renal PRMT1 increased, but DDAH2
decreased, which might result in the accumulation of
ADMA. Although ADMA level was not analyzed because of
limited blood volume in this study, we have shown elevated
ADMA level in adult 5/6 NX rats.2 Because kidney is a major
site of ADMA catabolism by DDAH, reduced nephron mass
could consequently influence renal metabolism of systemic
ADMA. On the other hand, increased PRMT1 expression
could also influence NO bioavailability by means of inducing
ADMA synthesis.
Dietary intervention with L-arginine has resulted in
amelioration of a number of experimental kidney diseases,9
including remnant kidney.10 However, whether L-arginine
level is decreased and whether L-arginine supplementation
is beneficial to children with CKD are inconclusive. ASS/
ASL, the two arginase isoenzymes, the three NOS isoen-
zymes, arginine decarboxylase, and cationic amino acid
transporters have been recognized as key factors in regu-
lating arginine metabolism.11 Nevertheless, their relative
importance in regulating NO production in CKD remains
unclear. Our study demonstrated that renal ASS/ASL and
arginase II abundances were decreased in neonatal 5/6 NX
rats, which was consistent with our recent findings showing
that a fall in L-arginine production in adult remnant kidney
is because of an early loss of ASS and ASL conversion of
citrulline.12 As fetal rat kidney is prone to express low ASS
expression compared with adult kidney,13 suggesting
a substantial L-arginine deficiency might occur because of
decreased L-arginine production in the neonatal remnant
kidney. As arginase pathway accounts for the major
consumption of L-arginine and arginase II is the major iso-
form expressed in the kidney, our data revealed NO defi-
ciency attributed to L-arginine deficiency might not mainly
be because of consumption by arginase in this model.
As with other models of experimentally induced CKD,
reduction of renal nNOSa and compensatory increase of
nNOSb are seen after 5/6 NX in neonates. Specific therapy
targeting NO deficiency might be a promising approach todelay CKD progression. Additionally, elucidation of the
differences and similarities in the mechanisms involved in
the progression of CKD in children and adults might provide
insights into prevention of childhood CKD.References
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